Developing Targeted Therapies to Address Heart Failure
Update: 2023-09-01
Description
Drew Titmarsh, Co-Founder and CEO of Dynomics, sits down with Neil to discuss that lack of innovative therapies to treat heat disease, the company’s discovery platform that uses engineered cardiac organoids that function like adult human heart tissue, and how the company is using this to develop precision therapies to address the root causes of heart failure.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
